The FDA has approved Medicis’ hyaluronic acid with lidocaine dermal fillers, Restylane-L and Perlane-L. This approval was based on clinical data that demonstrated Restylane-L and Perlane-L to ...

Twenty years ago, if you wanted to get rid of wrinkly, sagging skin, there was basically one way to do it--going under the knife for a face-lift. But today, a range of dermal fillers can be injected ...

Oct. 31 -- American women say they have found the fountain of youth in a syringe, but there's a catch: It's illegal to use in the United States. Hyaluronic acid, marketed under the names Restylane and ...

SCOTTSDALE, Ariz., April 27, 2011 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the U.S. Food and Drug Administration's (FDA) General and Plastic Surgery Devices Advisory Panel (the ...

Valeant Pharmaceuticals International, Inc. ( VRX) recently announced that it has inked a revised North American aesthetics deal with Galderma S.A. According to the terms of the modified deal, ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. The Skin and Vein Center of Troy, Westland, Southfield and ...

Ever-hungry Valeant Pharmaceuticals has added yet another company’s drug roster to its portfolio. Valeant announced Tuesday that it had bought up dermatology company Medicis for about $2.6 billion, or ...